Literature DB >> 1658684

Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas.

M J Glantz1, P C Burger, J E Herndon, A H Friedman, J G Cairncross, N A Vick, S C Schold.   

Abstract

Stereotactic biopsy of CNS tumors provides a small amount of tissue for pathologic diagnosis. This potentially leads to inaccurate grading of gliomas because of their histologic heterogeneity. We compared histologic diagnoses in a consecutive series of 329 patients with newly diagnosed anaplastic gliomas whose diagnoses were established by either stereotactic biopsy or open resection. Of 262 patients undergoing resection, 214 (82%) had glioblastomas and 48 (18%) had anaplastic astrocytomas (AAs). Of 67 patients undergoing stereotactic biopsy, 33 (49%) had glioblastomas and 34 (51%) had AAs. This difference suggests that some AAs diagnosed by stereotactic biopsy are actually glioblastomas and has important implications for the design and interpretation of clinical trials.

Entities:  

Mesh:

Year:  1991        PMID: 1658684     DOI: 10.1212/wnl.41.11.1741

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.

Authors:  Michail Plotkin; C Blechschmidt; G Auf; F Nyuyki; L Geworski; T Denecke; W Brenner; F Stockhammer
Journal:  Eur Radiol       Date:  2010-06-03       Impact factor: 5.315

2.  Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.

Authors:  L Chauveinc; M T Sola-Martinez; M Martin-Duverneuil; J J Mazeron; T Faillot; P Cornu; L Capelle; J Y Delattre; M Poisson; F Baillet; J Chiras
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

3.  High amino acid uptake in a low-grade desmoplastic infantile ganglioglioma in a 14-year-old patient.

Authors:  B Woesler; T Kuwert; G Kurlemann; C Morgenroth; S Probst-Cousin; H Lerch; F Gullotta; H Wassmann; O Schober
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

4.  Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma.

Authors:  K Lote; T Egeland; B Hager; K Skullerud; H Hirschberg
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

5.  Assessment of molecular markers demonstrates concordance between samples acquired via stereotactic biopsy and open craniotomy in both anaplastic astrocytomas and glioblastomas.

Authors:  Florian Gessler; Peter Baumgarten; Joshua D Bernstock; Patrick Harter; Stephanie Lescher; Christian Senft; Volker Seifert; Gerhard Marquardt; Lutz Weise
Journal:  J Neurooncol       Date:  2017-05-15       Impact factor: 4.130

6.  FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Authors:  Gabriele Pöpperl; Friedrich W Kreth; Jan H Mehrkens; Jochen Herms; Klaus Seelos; Walter Koch; Franz J Gildehaus; Hans A Kretzschmar; Jörg C Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

7.  Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection.

Authors:  Jeffrey S Wefel; Kyle R Noll; Ganesh Rao; Daniel P Cahill
Journal:  Neuro Oncol       Date:  2016-08-30       Impact factor: 12.300

8.  Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.

Authors:  Betty Y S Kim; Wen Jiang; Jason Beiko; Sujit S Prabhu; Franco DeMonte; Mark R Gilbert; Raymond Sawaya; Kenneth D Aldape; Daniel P Cahill; Ian E McCutcheon
Journal:  J Neurooncol       Date:  2014-04-29       Impact factor: 4.130

Review 9.  Through the patient's eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma.

Authors:  Adam M Robin; Steven N Kalkanis; Jack Rock; Ian Lee; Mark L Rosenblum
Journal:  J Neurooncol       Date:  2014-06-25       Impact factor: 4.130

10.  Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors.

Authors:  Sung Ki Cho; Dong Gyu Na; Jae Wook Ryoo; Hong Gee Roh; Chan Hong Moon; Hong Sik Byun; Jong Hyun Kim
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.